insights_auto
Why is AGIO down ४.५६%?
Dive Deeperchevron_right
AGIO:NASDAQ
Agios Pharmaceuticals Inc
US$ ३०.१५
arrow_downward
-४.५६%(-१.४४) 1D
US$ २९.५५
arrow_downward
-१.९९% (-०.६०)bedtimeAfter hours
Closed: नोभेम्बर १६, १६:००:०१ GMT-५ · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for AGIO...
Open
US$ ३१.२९
High
US$ ३१.७०
Low
US$ ३०.१०
Mkt. cap
१.८० अरब
Avg. vol.
१२.४२ लाख
Volume
५.४१ लाख
52-wk high
US$ ४५.९९
52-wk low
US$ २२.२४
EPS
-US$ ६.३२
Beta
०.६६
Shares outstanding
५.९८ करोड
No. of employees
५४०
Open
US$ ३१.२९
High
US$ ३१.७०
Low
US$ ३०.१०
Mkt. cap
१.८० अरब
Avg. vol.
१२.४२ लाख
Volume
५.४१ लाख
52-wk high
US$ ४५.९९
52-wk low
US$ २२.२४
EPS
-US$ ६.३२
Beta
०.६६
Shares outstanding
५.९८ करोड
No. of employees
५४०
News stories
From web sources and news partners
Stocktwits
·
२२ मिनेट पहिले
S&P 500, Dow, Nasdaq End Lower As Investors Hold Back Ahead Of Nvidia Earnings, Anthropic IPO This Week — NVDA, TSLA, ANT In Focus
Bloomberg.com
·
१ घण्टा पहिले
Wells Fargo Sees S&P 500 at 8,200 By End of 2027 as Profits Slow
ChartMill
·
४ घण्टा पहिले
S&P 500 Top Movers: Gainers and Losers for Nov. 16, 2026
Traders Union
·
१ घण्टा पहिले
Michael A. Gayed: S&P 500 fell 19.35% and high yield dropped 5.9% in Q4 2018 selloff
Profile
Agios Pharmaceuticals Inc. is a publicly trading American pharmaceutical company pioneering therapies for genetically defined diseases, with a near-term focus on developing therapies for hemolytic anemias. The company was founded in 2008 by Lewis Cantley, Tak Mak and Craig Thompson. Agios is a Delaware corporation headquartered in Cambridge, Massachusetts. The company tendered an initial public offering in July 2013. Wikipedia
About Agios Pharmaceuticals Inc